The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials

S. Conaty, L. Watson, J. Dinnes, Norman Robert Waugh

Research output: Contribution to journalEditorial

90 Citations (Scopus)

Abstract

The use of pneumococcal polysaccharide vaccine has remained controversial since licensure, especially in the elderly. Observational studies form much of the evidence base. We conducted a systematic review of observational studies and compared results with those obtained from an earlier review of randomised controlled trials (RCTs). Estimates of protection against invasive disease from observational studies were consistent, homogenous and compatible with sparse information obtained from RCTs. Studies were of moderate quality. From 13 observational studies the estimate of vaccine efficacy against invasive disease was 53% (46-59%) compared with 38% (-4 to 63%) from nine RCTs. Estimates of protection against all-cause pneumonia were based on fewer, heterogeneous studies that were not consistent with the findings from RCTs for this outcome. From five studies combined efficacy was 32% (7-50%) compared with 3% (-16 to 19%) from 13 RCTs. (C) 2004 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)3214-3224
Number of pages10
JournalVaccine
Volume22
Issue number23-24
DOIs
Publication statusPublished - Aug 2004

Keywords

  • pneumococcal infection
  • pneumococcal vaccines
  • meta-analysis
  • epidemiologic studies
  • immunisation
  • COMMUNITY-ACQUIRED PNEUMONIA
  • HUMAN-IMMUNODEFICIENCY-VIRUS
  • OBSTRUCTIVE PULMONARY-DISEASE
  • HIV-INFECTED PATIENTS
  • CHRONIC LUNG-DISEASE
  • AGED 65 YEARS
  • RISK-FACTORS
  • CLINICAL EFFECTIVENESS
  • PROTECTIVE EFFICACY
  • ELDERLY PERSONS

Cite this

The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials. / Conaty, S.; Watson, L.; Dinnes, J.; Waugh, Norman Robert.

In: Vaccine, Vol. 22, No. 23-24, 08.2004, p. 3214-3224.

Research output: Contribution to journalEditorial

@article{3c5377c051934665b82374d406dd9b3a,
title = "The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials",
abstract = "The use of pneumococcal polysaccharide vaccine has remained controversial since licensure, especially in the elderly. Observational studies form much of the evidence base. We conducted a systematic review of observational studies and compared results with those obtained from an earlier review of randomised controlled trials (RCTs). Estimates of protection against invasive disease from observational studies were consistent, homogenous and compatible with sparse information obtained from RCTs. Studies were of moderate quality. From 13 observational studies the estimate of vaccine efficacy against invasive disease was 53{\%} (46-59{\%}) compared with 38{\%} (-4 to 63{\%}) from nine RCTs. Estimates of protection against all-cause pneumonia were based on fewer, heterogeneous studies that were not consistent with the findings from RCTs for this outcome. From five studies combined efficacy was 32{\%} (7-50{\%}) compared with 3{\%} (-16 to 19{\%}) from 13 RCTs. (C) 2004 Elsevier Ltd. All rights reserved.",
keywords = "pneumococcal infection, pneumococcal vaccines, meta-analysis, epidemiologic studies, immunisation, COMMUNITY-ACQUIRED PNEUMONIA, HUMAN-IMMUNODEFICIENCY-VIRUS, OBSTRUCTIVE PULMONARY-DISEASE, HIV-INFECTED PATIENTS, CHRONIC LUNG-DISEASE, AGED 65 YEARS, RISK-FACTORS, CLINICAL EFFECTIVENESS, PROTECTIVE EFFICACY, ELDERLY PERSONS",
author = "S. Conaty and L. Watson and J. Dinnes and Waugh, {Norman Robert}",
year = "2004",
month = "8",
doi = "10.1016/j.vaccine.2003.08.050",
language = "English",
volume = "22",
pages = "3214--3224",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "23-24",

}

TY - JOUR

T1 - The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials

AU - Conaty, S.

AU - Watson, L.

AU - Dinnes, J.

AU - Waugh, Norman Robert

PY - 2004/8

Y1 - 2004/8

N2 - The use of pneumococcal polysaccharide vaccine has remained controversial since licensure, especially in the elderly. Observational studies form much of the evidence base. We conducted a systematic review of observational studies and compared results with those obtained from an earlier review of randomised controlled trials (RCTs). Estimates of protection against invasive disease from observational studies were consistent, homogenous and compatible with sparse information obtained from RCTs. Studies were of moderate quality. From 13 observational studies the estimate of vaccine efficacy against invasive disease was 53% (46-59%) compared with 38% (-4 to 63%) from nine RCTs. Estimates of protection against all-cause pneumonia were based on fewer, heterogeneous studies that were not consistent with the findings from RCTs for this outcome. From five studies combined efficacy was 32% (7-50%) compared with 3% (-16 to 19%) from 13 RCTs. (C) 2004 Elsevier Ltd. All rights reserved.

AB - The use of pneumococcal polysaccharide vaccine has remained controversial since licensure, especially in the elderly. Observational studies form much of the evidence base. We conducted a systematic review of observational studies and compared results with those obtained from an earlier review of randomised controlled trials (RCTs). Estimates of protection against invasive disease from observational studies were consistent, homogenous and compatible with sparse information obtained from RCTs. Studies were of moderate quality. From 13 observational studies the estimate of vaccine efficacy against invasive disease was 53% (46-59%) compared with 38% (-4 to 63%) from nine RCTs. Estimates of protection against all-cause pneumonia were based on fewer, heterogeneous studies that were not consistent with the findings from RCTs for this outcome. From five studies combined efficacy was 32% (7-50%) compared with 3% (-16 to 19%) from 13 RCTs. (C) 2004 Elsevier Ltd. All rights reserved.

KW - pneumococcal infection

KW - pneumococcal vaccines

KW - meta-analysis

KW - epidemiologic studies

KW - immunisation

KW - COMMUNITY-ACQUIRED PNEUMONIA

KW - HUMAN-IMMUNODEFICIENCY-VIRUS

KW - OBSTRUCTIVE PULMONARY-DISEASE

KW - HIV-INFECTED PATIENTS

KW - CHRONIC LUNG-DISEASE

KW - AGED 65 YEARS

KW - RISK-FACTORS

KW - CLINICAL EFFECTIVENESS

KW - PROTECTIVE EFFICACY

KW - ELDERLY PERSONS

U2 - 10.1016/j.vaccine.2003.08.050

DO - 10.1016/j.vaccine.2003.08.050

M3 - Editorial

VL - 22

SP - 3214

EP - 3224

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 23-24

ER -